Copyright Reports & Markets. All rights reserved.

Global Granulocyte Macrophage Colony Stimulating Factor Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Granulocyte Macrophage Colony Stimulating Factor Market Overview

      • 1.1 Product Overview and Scope of Granulocyte Macrophage Colony Stimulating Factor
      • 1.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Type
        • 1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 CG-0070
        • 1.2.3 Gimsilumab
        • 1.2.4 GSK-3196165
        • 1.2.5 Lenzilumab
        • 1.2.6 MGN-1601
        • 1.2.7 Others
      • 1.3 Granulocyte Macrophage Colony Stimulating Factor Segment by Application
        • 1.3.1 Granulocyte Macrophage Colony Stimulating Factor Consumption Comparison by Application (2014-2025)
        • 1.3.2 Solid Tumor
        • 1.3.3 Lymphoma
        • 1.3.4 Kidney Cancer
        • 1.3.5 Lung Disease
        • 1.3.6 Others
      • 1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market by Region
        • 1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Granulocyte Macrophage Colony Stimulating Factor Market Size
        • 1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue (2014-2025)
        • 1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Production (2014-2025)

      2 Global Granulocyte Macrophage Colony Stimulating Factor Market Competition by Manufacturers

      • 2.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Granulocyte Macrophage Colony Stimulating Factor Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Production Sites, Area Served, Product Types
      • 2.5 Granulocyte Macrophage Colony Stimulating Factor Market Competitive Situation and Trends
        • 2.5.1 Granulocyte Macrophage Colony Stimulating Factor Market Concentration Rate
        • 2.5.2 Granulocyte Macrophage Colony Stimulating Factor Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Regions

      • 3.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Regions
      • 3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Granulocyte Macrophage Colony Stimulating Factor Production
        • 3.4.1 North America Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
        • 3.4.2 North America Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Granulocyte Macrophage Colony Stimulating Factor Production
        • 3.5.1 Europe Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
        • 3.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Granulocyte Macrophage Colony Stimulating Factor Production (2014-2019)
        • 3.6.1 China Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
        • 3.6.2 China Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Granulocyte Macrophage Colony Stimulating Factor Production (2014-2019)
        • 3.7.1 Japan Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate (2014-2019)
        • 3.7.2 Japan Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Granulocyte Macrophage Colony Stimulating Factor Consumption by Regions

      • 4.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption by Regions
      • 4.2 North America Granulocyte Macrophage Colony Stimulating Factor Consumption (2014-2019)
      • 4.3 Europe Granulocyte Macrophage Colony Stimulating Factor Consumption (2014-2019)
      • 4.4 China Granulocyte Macrophage Colony Stimulating Factor Consumption (2014-2019)
      • 4.5 Japan Granulocyte Macrophage Colony Stimulating Factor Consumption (2014-2019)

      5 Global Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price Trend by Type

      • 5.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Market Share by Type (2014-2019)
      • 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2014-2019)
      • 5.3 Global Granulocyte Macrophage Colony Stimulating Factor Price by Type (2014-2019)
      • 5.4 Global Granulocyte Macrophage Colony Stimulating Factor Production Growth by Type (2014-2019)

      6 Global Granulocyte Macrophage Colony Stimulating Factor Market Analysis by Applications

      • 6.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Market Share by Application (2014-2019)
      • 6.2 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Granulocyte Macrophage Colony Stimulating Factor Business

      • 7.1 Aduro BioTech Inc
        • 7.1.1 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.1.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Amgen Inc
        • 7.2.1 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.2.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 BriaCell Therapeutics Corp
        • 7.3.1 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.3.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Cold Genesys Inc
        • 7.4.1 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.4.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 GlaxoSmithKline Plc
        • 7.5.1 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.5.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Humanigen Inc
        • 7.6.1 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.6.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Mologen AG
        • 7.7.1 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.7.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Morphotek Inc
        • 7.8.1 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.8.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Sillajen Biotherapeutics
        • 7.9.1 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.9.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Takeda Pharmaceutical Co Ltd
        • 7.10.1 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production Sites and Area Served
        • 7.10.2 Granulocyte Macrophage Colony Stimulating Factor Product Introduction, Application and Specification
        • 7.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Granulocyte Macrophage Colony Stimulating Factor Manufacturing Cost Analysis

      • 8.1 Granulocyte Macrophage Colony Stimulating Factor Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor
      • 8.4 Granulocyte Macrophage Colony Stimulating Factor Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Granulocyte Macrophage Colony Stimulating Factor Distributors List
      • 9.3 Granulocyte Macrophage Colony Stimulating Factor Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Granulocyte Macrophage Colony Stimulating Factor Market Forecast

      • 11.1 Global Granulocyte Macrophage Colony Stimulating Factor Production, Revenue Forecast
        • 11.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Price and Trend Forecast (2019-2025)
      • 11.2 Global Granulocyte Macrophage Colony Stimulating Factor Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Granulocyte Macrophage Colony Stimulating Factor Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Granulocyte Macrophage Colony Stimulating Factor Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Granulocyte Macrophage Colony Stimulating Factor Production, Revenue Forecast (2019-2025)
      • 11.3 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2019-2025)
        • 11.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2019-2025)
        • 11.3.3 China Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2019-2025)
        • 11.3.4 Japan Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2019-2025)
      • 11.4 Global Granulocyte Macrophage Colony Stimulating Factor Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Granulocyte Macrophage Colony Stimulating Factor market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Granulocyte Macrophage Colony Stimulating Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Granulocyte Macrophage Colony Stimulating Factor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Aduro BioTech Inc
        Amgen Inc
        BriaCell Therapeutics Corp
        Cold Genesys Inc
        GlaxoSmithKline Plc
        Humanigen Inc
        Mologen AG
        Morphotek Inc
        Sillajen Biotherapeutics
        Takeda Pharmaceutical Co Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        CG-0070
        Gimsilumab
        GSK-3196165
        Lenzilumab
        MGN-1601
        Others

        Segment by Application
        Solid Tumor
        Lymphoma
        Kidney Cancer
        Lung Disease
        Others

        Buy now